FDA Panel Recommends Expanded Cymbalta Uses
Aug 19th, 2010 | By Jose DeJesus MDEli Lilly’s drug, Cymbalta, was approved for lower back pain by an FDA scientific advsory panel. This is a follow up article to the dividend growth article published earlier today at http://physicianentrepreneur.com/?p=834